Thimble Point Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch THMAU and buy or sell other stocks, ETFs, and their options commission-free!About THMAU
Pear Therapeutics, Inc. is a commercial-stage healthcare company pioneering a new class of software-based medicines, sometimes referred to as Prescription Digital Therapeutics (PDT), which use software to treat diseases directly. The firm aims to redefine medicine by discovering, developing, and delivering clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. It has a pipeline of products and product candidates across therapeutic areas, including the first three PDTs with disease treatment claims from the FDA.
CEOChristopher D. T. Guiffre, MBA
CEOChristopher D. T. Guiffre, MBA
Employees—
Employees—
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2020
Founded2020
Employees—
Employees—
THMAU Key Statistics
Market cap341.55M
Market cap341.55M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume550.44
Average volume550.44
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$10.73
52 Week high$10.73
52 Week low$9.76
52 Week low$9.76
Stock Snapshot
Thimble Point Acquisition Corp. Unit(THMAU) stock is priced at $9.90, giving the company a market capitalization of 341.55M.
On 2025-12-12, Thimble Point Acquisition Corp. Unit(THMAU) stock opened at —, reached a high of —, and a low of —.
The Thimble Point Acquisition Corp. Unit(THMAU)'s current trading volume is 0, compared to an average daily volume of 550.44.
During the past year, Thimble Point Acquisition Corp. Unit(THMAU) stock moved between $9.76 at its lowest and $10.73 at its peak.
During the past year, Thimble Point Acquisition Corp. Unit(THMAU) stock moved between $9.76 at its lowest and $10.73 at its peak.